Menu
Back to User profile » Professor Azzam A Maghazachi
Papers published by Professor Azzam A Maghazachi:
Globoid Cell Leukodystrophy (Krabbe Disease): An Update
Maghazachi AA
ImmunoTargets and Therapy 2023, 12:105-111
Published Date: 31 October 2023
Molecular Examination of Differentially Expressed Genes in the Brains of Experimental Autoimmune Encephalomyelitis Mice Post Herceptin Treatment
Al-Ani M, Elemam NM, Hachim IY, Raju TK, Muhammad JS, Hachim MY, Bendardaf R, Maghazachi AA
Journal of Inflammation Research 2021, 14:2601-2617
Published Date: 17 June 2021
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Dhaiban S, Al-Ani M, Elemam NM, Maghazachi AA
Journal of Inflammation Research 2020, 13:619-633
Published Date: 29 September 2020
Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?
Al-Ani M, Elemam NM, Hundt JE, Maghazachi AA
Infection and Drug Resistance 2020, 13:3243-3254
Published Date: 22 September 2020
Rituximab Prevents the Development of Experimental Autoimmune Encephalomyelitis (EAE): Comparison with Prophylactic, Therapeutic or Combinational Regimens
Al-ani MR, Raju TK, Hachim MY, Hachim IY, Elemam NM, Guimei M, Bendardaf R, Maghazachi AA
Journal of Inflammation Research 2020, 13:151-164
Published Date: 10 March 2020
Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis
Elemam NM, Hannawi S, Maghazachi AA
ImmunoTargets and Therapy 2020, 9:43-56
Published Date: 9 March 2020
Gasdermin D Hypermethylation Inhibits Pyroptosis And LPS-Induced IL-1β Release From NK92 Cells
Muhammad JS, Jayakumar MN, Elemam NM, Venkatachalam T, Raju TK, Hamoudi RA, Maghazachi AA
ImmunoTargets and Therapy 2019, 8:29-41
Published Date: 14 October 2019
Implications of chemokine receptors and inflammatory lipids in cancer
Rolin J, Maghazachi AA
ImmunoTargets and Therapy 2014, 3:9-18
Published Date: 24 December 2013